CCR2/5 receptor antagonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CCR2/5 receptor antagonist, covering 2016-10-17 to 2016-10-17. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema [Phase 2]